FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800726265> ?p ?o ?g. }

• W2800726265 endingPage "1195" @default.
• W2800726265 startingPage "1185" @default.
• W2800726265 abstract "Abstract Glioblastoma multiforme (GBM) is the most common brain malignancies in adults. Most GBM patients succumb to the disease less than 1 year after diagnosis due to the highly invasive nature of the tumor, which prevents complete surgical resection and gives rise to tumor recurrence. The invasive phenotype also confers radioresistant and chemoresistant properties to the tumor cells; therefore, there is a critical need to develop new therapeutics that target drivers of GBM invasion. Amplification of EGFR is observed in over 50% of GBM tumors, of which half concurrently overexpress the variant EGFRvIII, and expression of both receptors confers a worse prognosis. EGFR and EGFRvIII cooperate to promote tumor progression and invasion, in part, through activation of the Stat signaling pathway. Here, it is reported that EGFRvIII activates Stat5 and GBM invasion by inducing the expression of a previously established mediator of glioma cell invasion and survival: fibroblast growth factor-inducible 14 (Fn14). EGFRvIII-mediated induction of Fn14 expression is Stat5 dependent and requires activation of Src, whereas EGFR regulation of Fn14 is dependent upon Src–MEK/ERK–Stat3 activation. Notably, treatment of EGFRvIII-expressing GBM cells with the FDA-approved Stat5 inhibitor pimozide blocked Stat5 phosphorylation, Fn14 expression, and cell migration and survival. Because EGFR inhibitors display limited therapeutic efficacy in GBM patients, the EGFRvIII–Stat5–Fn14 signaling pathway represents a node of vulnerability in the invasive GBM cell populations. Implications: Targeting critical effectors in the EGFRvIII–Stat5–Fn14 pathway may limit GBM tumor dispersion, mitigate therapeutic resistance, and increase survival. Mol Cancer Res; 16(7); 1185–95. ©2018 AACR." @default.
• W2800726265 created "2018-05-17" @default.
• W2800726265 creator A5016790638 @default.
• W2800726265 creator A5016981455 @default.
• W2800726265 creator A5031163794 @default.
• W2800726265 creator A5032029297 @default.
• W2800726265 creator A5034505930 @default.
• W2800726265 creator A5038787174 @default.
• W2800726265 creator A5039594069 @default.
• W2800726265 creator A5055772664 @default.
• W2800726265 creator A5055835029 @default.
• W2800726265 creator A5059934426 @default.
• W2800726265 creator A5083325281 @default.
• W2800726265 creator A5086644261 @default.
• W2800726265 date "2018-07-01" @default.
• W2800726265 modified "2023-09-30" @default.
• W2800726265 title "EGFRvIII–Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival" @default.
• W2800726265 cites W1573931073 @default.
• W2800726265 cites W1690635788 @default.
• W2800726265 cites W1971977403 @default.
• W2800726265 cites W1978177843 @default.
• W2800726265 cites W1983159021 @default.
• W2800726265 cites W1989223905 @default.
• W2800726265 cites W1997480385 @default.
• W2800726265 cites W2002729585 @default.
• W2800726265 cites W2007528734 @default.
• W2800726265 cites W2012855199 @default.
• W2800726265 cites W2013878898 @default.
• W2800726265 cites W2018338444 @default.
• W2800726265 cites W2020344403 @default.
• W2800726265 cites W2023952192 @default.
• W2800726265 cites W2024970329 @default.
• W2800726265 cites W2025183726 @default.
• W2800726265 cites W2025357617 @default.
• W2800726265 cites W2025677699 @default.
• W2800726265 cites W2032644486 @default.
• W2800726265 cites W2033987226 @default.
• W2800726265 cites W2043696829 @default.
• W2800726265 cites W2048043668 @default.
• W2800726265 cites W2051577500 @default.
• W2800726265 cites W2053353977 @default.
• W2800726265 cites W2054727624 @default.
• W2800726265 cites W2055145844 @default.
• W2800726265 cites W2061070237 @default.
• W2800726265 cites W2061701210 @default.
• W2800726265 cites W2068789057 @default.
• W2800726265 cites W2073723168 @default.
• W2800726265 cites W2076496694 @default.
• W2800726265 cites W2077177292 @default.
• W2800726265 cites W2085046739 @default.
• W2800726265 cites W2096287682 @default.
• W2800726265 cites W2107312134 @default.
• W2800726265 cites W2109816625 @default.
• W2800726265 cites W2117139777 @default.
• W2800726265 cites W2129763580 @default.
• W2800726265 cites W2131719301 @default.
• W2800726265 cites W2135823227 @default.
• W2800726265 cites W2136734008 @default.
• W2800726265 cites W2139923932 @default.
• W2800726265 cites W2148977460 @default.
• W2800726265 cites W2150037470 @default.
• W2800726265 cites W2157379134 @default.
• W2800726265 cites W2160008014 @default.
• W2800726265 cites W2160511594 @default.
• W2800726265 cites W2161008794 @default.
• W2800726265 cites W2170753913 @default.
• W2800726265 cites W2171411676 @default.
• W2800726265 cites W2205491921 @default.
• W2800726265 cites W2220215167 @default.
• W2800726265 cites W2238014838 @default.
• W2800726265 cites W2312738416 @default.
• W2800726265 cites W2319926262 @default.
• W2800726265 cites W2344575109 @default.
• W2800726265 cites W2423833205 @default.
• W2800726265 cites W2575699548 @default.
• W2800726265 cites W2625826824 @default.
• W2800726265 cites W2625848096 @default.
• W2800726265 cites W4245392732 @default.
• W2800726265 doi "https://doi.org/10.1158/1541-7786.mcr-18-0125" @default.
• W2800726265 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6030495" @default.
• W2800726265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29724813" @default.
• W2800726265 hasPublicationYear "2018" @default.
• W2800726265 type Work @default.
• W2800726265 sameAs 2800726265 @default.
• W2800726265 citedByCount "35" @default.
• W2800726265 countsByYear W28007262652018 @default.
• W2800726265 countsByYear W28007262652019 @default.
• W2800726265 countsByYear W28007262652020 @default.
• W2800726265 countsByYear W28007262652021 @default.
• W2800726265 countsByYear W28007262652022 @default.
• W2800726265 countsByYear W28007262652023 @default.
• W2800726265 crossrefType "journal-article" @default.
• W2800726265 hasAuthorship W2800726265A5016790638 @default.
• W2800726265 hasAuthorship W2800726265A5016981455 @default.
• W2800726265 hasAuthorship W2800726265A5031163794 @default.
• W2800726265 hasAuthorship W2800726265A5032029297 @default.
• W2800726265 hasAuthorship W2800726265A5034505930 @default.
• W2800726265 hasAuthorship W2800726265A5038787174 @default.

• next